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Introduction: The apoptosis and subsequent injury of podocytes plays a pathogenic role in diabetic nephropathy
(DN). Mesenchymal stem cells (MSCs) are promising therapeutic cells for preventing apoptosis and reducing cellular
injury. Our previous study found that MSCs could protect kidneys from diabetes-induced injury without obvious
engraftment. So we evaluated the effects of human adipose-derived MSCs (hAd-MSCs) on podocytic apoptosis and
injury induced by high glucose (HG) and the underlying mechanisms.
Methods: We used flow cytometry, Western blot and confocal fluorescence microscopy to study podocytic apoptosis and
injury induced by HG at 24 hours, 48 hours, and 72 hours in the presence or absence of MSC-conditioned medium (CM).
An antibody-based cytokine array was used to identify the mediating factor, which was verified by adding the neutralizing
antibody (NtAb) to block its function or adding the recombinant cytokine to the medium to induce its function.
Results: hAd-MSC-CM reduced podocytic apoptosis in a dose-dependent manner, decreased the expression of podocytic
cleaved caspase-3, and prevented the reduced expression and maintained the normal arrangement of podocytic
synaptopodin and nephrin. However, human embryonic lung cell (Wi38)-CM failed to ameliorate podocytic apoptosis or
injury. Twelve cytokines with concentration ratios (MSC-CM/Wi38-CM) >10-fold were identified. Epithelial growth factor
(EGF) was singled out for its known ability to prevent apoptosis. Recombinant human EGF (rhEGF) prevented podocytic
apoptosis and injury similarly to hAd-MSC-CM but, upon blockade of EGF, the beneficial effect of hAd-MSC-CM decreased
dramatically.
Conclusions: hAd-MSCs prevent podocytic apoptosis and injury induced by HG, mainly through secreting soluble EG.
Keywords: Apoptosis, Diabetic nephropathy, Epithelial growth factor, Injury, Mesenchymal stem cells, PodocyteIntroduction
Diabetic nephropathy (DN) is one of the most common
and serious complications of capillaries in patients with
diabetes [1]. In recent years, research on the structure
and function of the filtration barrier of the glomerulus
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reproduction in any medium, provided the oroccurrence and development of DN [2]. Podocytes are
terminally differentiated epithelial cells attached to the
glomerular basement membrane, and the alternative
podocytic processes between adjacent podocytes con-
struct the slit diaphragm, which plays an important role
in maintaining the integrity of the filtration barrier
structure and function of the glomerulus [3-5]. High
glucose contributes to reduced podocyte number and in-
duces apoptosis of cultured podoctes and causes albu-
minuria and accelerates foot process effacement
[2,3,6,7]. At present, there is no satisfactory method or
target for the treatment of DN.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Li et al. Stem Cell Research & Therapy 2013, 4:103 Page 2 of 11
http://stemcellres.com/content/4/5/103Mesenchymal stem cells (MSCs), a group of cells from
the mesoblast that have characteristics of stem cells,
show strong proliferation ability and multipotential dif-
ferentiation, which can repair injured tissues and cells by
secreting cytokines [8-10]. Treatments involving MSCs
may be effective for repairing injured tissues and cells
clinically [8,11]. It has been shown that MSCs can pro-
mote tissue repair through chemotaxis and homing to
the damaged location in vivo, or through the paracrine
action of various cytokines, to reduce adverse reactions
of the kidney, so as to improve and promote the
endogenous repair of kidney tissue [12-15]. It is easy to
obtain MSCs from adipose tissue, which has stable
cellularity. After high passage of these cells, only a low
level of senescence will occur [16]. These cells have the
ability to secrete a large number of protective cytokines
[17,18] and show other MSCs characteristics, such as
self-renewal and multiple lineage differentiation. In pre-
liminary experiments, we found that human adipose-
derived (hAd)-MSCs injected via the tail vein into rats
with DN alleviated kidney injury, reduced proteinurea,
and prevented the downregulation of synaptopodin (data
not shown); however, the gross presence of stem cells
was not found in the kidney. Thus, we speculated that
hAd-MSCs protected the kidney via paracrine action.
Using hAd-MSC-conditioned medium (CM) with a
model of podocytic apoptosis induced by high glucose
(HG), we investigated whether MSCs-CM could itself in-
hibit HG-induced podocytic apoptosis, to identify the ef-
fect or molecule(s) and to provide novel insights into the
treatment of DN.Methods
Cell culture and processing
A mouse podocyte clone 5 (MPC5), which was provided
by Professor Peter Mundel of the Medical College of
Harvard University (Boston, MA, USA), was cultured as
previously described [16,19]. Briefly, cryopreserved po-
docytes were cultured and amplified in 11 mM D-
glucose Roswell Park Memorial Institute (RPMI)-1640
medium containing 20 units/ml IFN-γ (Invitrogen,
Carlsabad, CA, USA) and 10% FCS at 33°C. After pas-
sage at 37°C, the podocytes were cultured in IFN-γ-
free medium for 10 days (changing the solution every
two days) to induce differentiation. The presence of
synaptopodin and nephrin indicated podocytic differen-
tiation and was detected by confocal microscopy. The
cells were cultured synchronously in medium containing
0.2% FCS and 5.5 mM D-glucose RPMI-1640 medium
for 24 hours before the experiment. MPC5 cells were
divided mainly into seven groups according to
treatment: normal glucose (NG, 5.5 mM), mannitol con-
trol (NG+Ma, 5.5 mM D-glucose + 24.5 mM mannitol),HG (30 mM), treatment group in human embryonic
lung cells (Wi38)-CM (1×, 2×, 4×), treatment group in
MSC-CM (1×, 2×, 4×), recombinant human epidermal
growth factor (rhEGF, 3 ng/ml) treatment group, and
MSC-CM neutralizing antibody (MSC-CM+EGF+NtAb)
group.
hAd-MSCs were provided by the Microcirculation
Institute of the Chinese Academy of Medical Sciences
(Beijing, China). These cells from patients undergoing
selective suction-assisted lipectomy were collected
after obtaining informed consent from the patients
according to procedures approved by the Ethics
Committtee of the Chinese Academy of Medical Sci-
ences and Peking Union Medical College. The adipose
tissue was extensively washed with D-Hanks’ solution
to remove contaminating blood cells and local anes-
thetics. Then, it was resuspended in 0.075% typeΙA
collagenase (Sigma-Aldrich Corp, St. Louis, MO,
USA)/Hank's Balanced Salt Solution (approximately 2
ml/g) and incubated at 37°C for one hour to release
the cellular fractions. The digested adipose tissue was
passed through a 100-μm filter to remove debris and
centrifuged at 150 × g for 10 minutes to produce a
cell pellet. After isolation, 30 ml of resuspended cells
were plated in expansion medium at a density of 5 to
approximately 6 × 106 nucleated cells/75 cm2 tissue
culture dish and incubated at 37°C. Once adherent
cells were more than 80% confluent, they were
detached with 0.125% trypsin and 0.01%
ethylenediaminetetraacetic acid (EDTA) and replated
at a 1:4 dilution under the same conditions according
to previous protocols [16,20]. All the experiments
were done with the 5th passage and the 20th passage
and the 5th passage of hAd-MSCs was used for the
results given in this article.
Wi38 were purchased from the American Type Cul-
ture Collection (ATCC, Manassas, VA, USA) and were
cultured in RPMI-1640 medium containing 10% FCS
and passaged when confluence reached 80%.
Preparation of CM
hAd-MSCs and Wi38 cells were cultured in their re-
spective media at a concentration of 1 × 105 cells/cm2
and were rinsed three times in PBS after one day of cell
adhesion. Then, the cells were cultured in serum-free
RPMI-1640 medium for 48 hours and the culture
supernatants were collected. The supernatants were
centrifuged at 1,500 rpm for 10 minutes at 4°C and
transferred to a centrifugal column with a 3 kDa cut-off
(Millipore, Billerica, MA, USA). This resulted in 15×
MSC-CM or Wi38-CM, respectively, which were desal-
ted according to the manufacturer’s protocol. CM was
then sterilized by filtration through a 220 nm filter
(Millipore, Billerica, MA, USA).
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detected by Western blot
MPC5 cells were collected, and the total protein was
extracted. The protein concentration was determined by
BCA assay (Pierce, Rockford, IL, USA), and 2× SDS-
denatured protein (95°C for 5 minutes and ice-bath for
10 minutes) in the same volume was added. The total
protein of podocytes was isolated using 15% SDS-PAGE
and 80 μg of each sample. The isolated protein was
transferred to a nitrocellulose membrane. The primary
rabbit polyclonal anti-cleaved caspase-3 antibody (Cell
Signaling Technology, Beverly, MA, USA) was diluted
1:1000 and incubated with the membrane(s) overnight at
4°C. Then the secondary anti-rabbit antibody (Santa
Cruz Biotechnology, Santa Cruz, CA, USA), conjugated
to horseradish peroxidase (HRP) and diluted to 1:1000,
was added for one hour at room temperature. β-actin
was used as the loading control and the blots were de-
veloped with an ECL Western Blotting kit (Applygen
Technologies Inc, Beijing, China).
Podocytic apoptosis detected by flow cytometry
After the podocytes treated by different methods were
cultured at 37°C for 24, 48, and 72 hours, respectively,
and were digested with 0.25% EDTA-free pancreatin
(Gibco, Grand Island, NY, USA), they were rinsed twice
in PBS. The cell concentration was adjusted to 1 × 106
cells/L to make a single cell suspension. An annexin V/
propidium iodide (PI) double staining apoptosis detec-
tion kit (BD Biosciences, Franklin Lakes, NJ, USA) was
used to stain the podocytes according to the manufac-
turer’s instructions. The data were acquired on a flow
cytometer (Beckman Coulter Inc, CA, USA).
After the podocytes treated by different methods were
cultured at 37°C for 24, 48, and 72 hours, respectively, the
cell concentration was adjusted to 1 × 106 cells/L to make
a single cell suspension. When the apoptosis models were
established, reflecting the degree of apoptosis, was mea-
sured using flow cytometry with TUNEL staining. An In
Situ Cell Death Detection Kit (Roche, Mannheim,
Germany) was used to stain podocytes according to the
manufacturer’s instructions. The data were also acquired
on a flow cytometer (Beckman Coulter Inc).
Cellular immunofluorescence
Differentiated and matured podocytes were seeded onto
six-pore plates and covered by a cover glass that was
pretreated with collagen I (Sigma-Aldrich, St. Louis,
MO, USA). Each group was subjected to its own desig-
nated treatment regimen, and the cells were cultured at
37°C for 24, 48 and 72 hours, respectively. Three
accessory foramina were set up for each group at each
time point. The cells were fixed with 4% paraformalde-
hyde for 5 minutes at room temperature followed byincubation at 4°C for 10 minutes. Then, 0.2% Triton X-
100 was added to permeabilize the cells for 5 minutes at
room temperature and 1× casin was sealed up for 30 mi-
nutes at room temperature. Primary rabbit polyclonal
antibodies specific for synaptopodin and nephrin were di-
luted 1:50 and incubated with the cells (Santa Cruz Biotech-
nology) (ProSci Incorporated, San Diego, California, USA)
overnight at 4°C. A secondary anti-rabbit antibody conju-
gated to Cy3 (Jackson ImmunoResearch Laboratories,
Bar Harbor, ME, USA) (diluted 1:1000) was incu-
bated with the cells away from light for one hour at
room temperature. Finally, a fluorescent sealing liquid
(ZSGB-BIO, Beijing, China) containing 4',6-diamidino-2-
phenylindole (DAPI) was added, and confocal laser scan-
ning microscopy (FluoView FV1000; Olympus America
Inc., Center Valley, PA, USA) was used to determine the
expression level and structure arrangement of podocytic
synaptopodin and nephrin. Ten visual fields were
observed at random in each culture pore.
Antibody chip
A cytokine detection kit (RayBio Human Cytokine
Array; RayBiotech, Inc., Norcross, GA, USA) was used
to determine the presence of cytokines in the 15× con-
centrated blank RPMI-1640 medium, Wi38-CM, and
Ad-MSCs-CM. The analysis was performed using the
manufacturer’s recommended protocol, and the signals
of Cy3 were imaged by Axon GenePix laser scanner
(MDS Analytical Technologies, Sunnyvale, CA, USA).
The result was normalized to the respective positive
control. Results were obtained from three independent
samples.
Cytokines detected by enzyme-linked immunosorbent
assay (ELISA)
The concentration of EGF, insulin-like growth factor
binding protein (IGFBP)-1, glial cell line-derived neuro-
trophic factor (GDNF) and placental growth factor
(PIGF) was determined in each culture supernatant
(RPMI-1640 medium, Wi38-CM and Ad-MSC-CM) by
ELISA kits (R&D Systems, Minneapolis, MN, USA)
according to the manufacturer’s instructions. Optical
density (OD) was measured at 450 nm and 570 nm.
Concentration analysis software (Microplate Manager
4.0) was used to calculate the concentration of candidate
factors in the samples according to standard curves.
Three independent samples were placed in three repeti-
tive holes.
Recombinant factor and NtAb experiments
To prepare rhEGF, rhIGFBP-1, rhGDNF and rhPIGF,
the respective lyophilized powders (PeproTech, RockyHill,
NJ, USA) were reconstituted to a working concentration
Figure 1 (See legend on next page.)
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Figure 1 High glucose (HG) induces apoptosis and injury of mouse podocyte clone (MPC5) cells. A) AnnexinV/PI double-staining-labeled
cells in each group (n = 3 per group). The number of apoptotic or necrotic cells was quantified by FACS analysis after staining with annexin V and PI.
The cytograms show viable cells that did not bilnd annexin V or PI in the D3 quadrant. Cells at early stages of apoptosis that bound annexin V but that
still had intact cell membranes and excluded PI are shown in the D4 quadrant. Cells with advanced stages of apoptosis or necrotic were both annexin
V and PI positive and are shown in the D2 quadrant. Cells lost its intact cell membranes that bound PI and excluded annexin V are shown in the D1
quadrant. The results showed that podocytic apoptosis rate was significantly higher at all time points in HG group than in normal glucose (NG) group,
and was time-dependent. B)Western blot was used to detect the expression of cleaved caspase-3 at three time points (24, 48 and 72 hours). The
expression of cleaved caspase-3 was increased with the prolonged stimulation of HG. All of the experiments were repeated three times (n = 3). *P
<0.05, HG group versus NG group or NG+mannitol group; #P <0.05, 48-hour HG group or 72-hour HG group versus 24-hour HG group. C) The
expression and the location of podocytic cytoskeletal protein synaptopodin (red) were measured by confocal microscopy. The expression of podocytic
synaptopodin in the HG group was reduced and rearranged. Nuclei were stained with DAPI (blue). Magnification = 600×, 1800×. D) Using flow
cytometry with TUNEL staining to measure the apoptosis rate of podocytes under treatment with NG, NG+Ma and HG at three time points (24, 48 and
72 hours) (n = 3 each group). Cells analyzed under marker ‘A’ are apoptotic (TUNEL positive).
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served at −20°C.
A solution of rhEGF NtAb (PeproTech, Rocky Hill,
NJ, USA) was diluted using the respective CM to a ratio
(EGF: EGF-NtAb) of 1 ng/ml : 0.175 μg/ml and was in-
cubated at 37°C for one hour before using.
Statistical analysis
Analysis was done using SPSS 17.0 software. Results are
presented as mean ± standard deviation. One-factor ana-
lysis of variance (one-way ANOVA) was used to com-
pare differences among groups. P <0.05 was considered
statistically significant for all analyses.
Results
Podocytic apoptosis and injury was induced by HG
MPC5 cells were cultured in vitro and glucose (30 mM)
was added to induce apoptosis to establish a model of
podocytic apoptosis and injury. AnnexinV/PI double
staining and flow cytometry were used to detect podocytic
apoptosis, and the results showed that podocytic apoptosis
rates were significantly higher at all time points in the HG
group than in the NG group and were time-dependent (P
<0.05) (Figure 1A). Western blot was used to detect
cleaved caspase-3. The expression of cleaved caspase-3 in-
creased more with the prolonged stimulation HG (P
<0.05) (Figure 1B). Confocal immunofluorescence was
used to detect the expression of synaptopodin (one of
podocytic skelemins), and the results showed that the ex-
pression of podocytic synaptopodin in the HG group was
reduced and rearranged, while these changes did not
occur in the NG+Ma group (Figure 1C). The data suggest
that podocytic apoptosis and injury was induced by the in-
creased concentration of glucose, which was aggravated
with prolonged stimulation time.
hAd-MSC-CM reduced podocytic apoptosis and injury
induced by HG
After establishing a model of podocytic apoptosis and
injury induced by HG in vitro, we used MSC-CM toculture podocytes in HG. hAd-MSCs can be easily har-
vested from patients in a simple, minimally invasive
lipoaspiration procedure and can be expanded in vitro
[20]. Both hAd-MSCs and Wi38 are human fibroblasts,
but Wi38-CM does not have the characteristics of hAd-
MSCs. As a kind of stem cell, hAd-MSCs have the char-
acteristics of self-renewal and multi-differentiation. In
addition, hAd-MSCs have a characterized cytokine se-
cretion profile which Wi38 does not. So, we used Wi38-
CM as the control [21,22]. Compared with the HG
group, hAd-MSC-CM reduced podocytic apoptosis in-
duced by HG in a dose-dependent manner (P <0.05)
(Figure 2A and D), downregulated activated caspase-3
(P <0.05) (Figure 2B), and prevented the downregulation
and rearrangement of synaptopodin (Figure 2C). How-
ever, in the Wi38-CM treatment group, there was no
significant improvement in these same measures
(Figure 2B). Consequently, MSC-CM could prevent
podocytic apoptosis induced by HG and reduce the
injury of podocytic skelemins, but Wi38-CM could
not. Therefore, it was the cytokines present in MSC-
CM but not in Wi38-CM that contributed to pro-
tecting podocytes from the influence of HG.Screening of candidate factors in MSC-CM
We used an antibody-based cytokine array to detect the
cytokines in MSC-CM and Wi38-CM and selected the
following cytokines with MSC-CM/Wi38-CM >10: basic
fibroblast growth factor (bFGF) (3,381-fold), EGF (117-
fold), IGFBP-1 (45-fold), GDNF (30-fold), and PIGF
(123-fold).
It was reported that bFGF could augment podocyte
damage, resulting in increased glomerular protein per-
meability and accelerated glomerulosclerosis [23]. We
used ELISA kits to measure the concentration of cy-
tokines in CM: EGF (MSC-CM, 3.81 ± 0.18 ng/ml;
Wi38-CM, 29 ± 1.1 pg/ml), IGFBP-1 (MSC-CM, 0.98 ±
0.01 ng/ml; Wi38-CM, 21.7 ± 1.9 pg/ml), GDNF (MSC-
CM, 3.37 ± 0.12 ng/ml; Wi38-CM, 119 ± 21 pg/ml),
Figure 2 Human adipose-derived mesenchymal stem cells (hAd-MSCs)-conditioned medium (CM) reduces apoptosis and injury of
mouse podocyte clone (MPC5) cells induced by high glucose (HG). A) Representative photographs of annexinV/PI double-staining in
different groups (n = 3 per group) and flow cytometry to test the podocytic apoptosis rate after culture in Wi38-CM or MSC-CM. MSC-CM
reduced podocytic apoptosis in a dose-dependent manner, but Wi38-CM did not. B) Western blot was used to detect the expression of cleaved
caspase-3 at three time points (24, 48 and 72 hours). MSC-CM reduced the expression of cleaved caspase-3, but Wi38-CM did not. All of the
experiments were repeated three times (n = 3). *P <0.05 HG group versus normal glucose (NG) group or MSC-CM group; #P <0.05, 48-hour HG
group or 72-hour HG group versus 24-hour HG group. C) The expression and location of the podocytic cytoskeletal protein synaptopodin (red)
were measured by confocal microscopy. MSC-CM prevented the downregulation and rearrangement of synaptopodin, but Wi38-CM did not.
Nuclei were stained with DAPI (blue). Magnification = 600×, 1800×. D) Using flow cytometry with TUNEL staining to measure the apoptosis rate
of podocytes under treatment with NG, HG and MSCs-CM at three time points (24, 48 and 72 hours) (n = 3 each group). Cells analyzed under
marker ‘A’ are apoptotic (TUNEL positive). The results showed that the podocytic apoptosis rate was significantly lower at all time points in the
MSCs-CM group than in the HG group. DAPI, 4',6-diamidino-2-phenylindole; PI, propidium iodide.
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45.8 ± 2.2 pg/ml).
Based on these results, we prepared one-component
culture medium to podocytes in HG and used flow cy-
tometry to detect podocytic apoptosis. Results showed
that rhEGF (3.5 ng/ml) effectively inhibited podocytic
apoptosis induced by HG (P <0.05) compared with the
HG group, but rhIGFBP, rhGDNF, or rhPIGF (1 ng/ml,
3 ng/ml, 1 ng/ml) could not (Figure 3C). Therefore,
we chose EGF as the candidate cytokine for further in-
vestigation (Figure 3).
hAd-MSCs reduce podocytic apoptosis and injury induced
by HG through secreting EGF
To verify that EGF was the effector molecule in CM, we
cultured MPC5 cells in the presence of HG plus MSC-
CM, CM in which EGF was blocked by NtAb, or rhEGF
one-component CM. Podocytic apoptosis was detected
by annexinV/PI double staining and flow cytometry,
cleaved caspase-3 was detected by Western blot and theFigure 3 Screening candidate effector factors in human adipose-deriv
(CM). A) Cytokine microarray to determine the soluble cytokines present in
Wi38-CM >10: basic fibroblast growth factor (bFGF) (3,381-fold), epithelial g
(IGFBP)-1 (45-fold) and glial cell line-derived neurotrophic factor (GDNF) (30
B) The concentration of EGF in CM was determined by ELISA. MSC-CM: 3.8
CM versus blank medium; #P <0.05, MSC-CM versus Wi38-CM. C) AnnexinV/
flow cytometry to determine the podocytic apoptosis rate. Growth factor (
(IGFBP, GDNF, PIGF) did not. PI, propidium iodide.expression of synaptopodin and nephrin was detected by
confocal immunofluorescence. Compared with the HG
group, rhEGF significantly prevented podocytic apop-
tosis induced by HG as shown by the apoptosis rate
(P <0.05) (Figure 4A) and the expression of cleaved
caspase-3 (P <0.05) (Figure 4B), and reduced podocytic
injury as shown by the expression and the arrangement
of synaptopodin and nephrin. However, after blocking
EGF in MSC-CM with NtAb, the aforementioned the-
rapeutic effect of MSC-CM was significantly decreased
(P <0.05) (Figure 4C and D).
Discussion
Podocytes not only take part in the formation of the fil-
tration barrier but also express many kinds of protein
molecules, including synaptopodin and nephrin. The
synaptopodin protein of podocytic skelemins is a marker
of podocytic differentiation and maturation, which can
maintain the normal morphology of podocytes, the nor-
mal structure of the glomerular filtration membrane anded mesenchymal stem cells (hAd-MSCs)-conditioned medium
blank medium, Wi38-CM and MSC-CM. Cytokines of MSC-CM/
rowth factor (EGF) (117-fold), insulin-like growth factor binding protein
-fold). The data were normalized to the respective positive controls.
1 ± 0.18 ng/ml; Wi38-CM: 29 ± 1.1 pg/ml. *P <0.05 Wi38-CM or MSC-
PI double staining labeled cells in each group (n = 3 per group) and
EGF) significantly reduced podocytic apoptosis,but other factors
Figure 4 Epithelial growth factor (EGF) is the main factor in human adipose-derived mesenchymal stem cells (hAd-MSCs)-conditioned
medium (CM) to reduce apoptosis and injury of mouse podocyte clone (MPC5) cells induced by high glucose (HG). A) AnnexinV/PI
double staining labeled cells in each group (n = 3 per group) and flow cytometry to determine podocytic apoptosis rate. Recombinant human
(rh) EGF group significantly reduced podocytic apoptosis but EGF-neutralizing antibody (NtAb) did not. B) Western blot was used to detect the
expression of cleaved caspase-3 at three time points (24, 48 and 72 hours). rhEGF reduced the expression of cleaved caspase-3, but EGF-NtAb did
not. All of the experiments were repeated three times (n = 3). *P <0.05 HG group versus normal glucose (NG) group, MSC-CM group or rhEGF
group; #P <0.05, EGF-NtAb versus NG group, MSC-CM group or rhEGF group. C) The expression and the location of the podocytic cytoskeletal
protein synaptopodin (red) were measured by confocal microscopy. rhEGF prevented the downregulation and rearrangement of synaptopodin
but EGF-NtAb did not. Nuclei were stained with DAPI (blue). Magnification = 600×, 1800×. D) The expression of the podocytic membrane protein
nephrin (red) was measured by confocal microscopy. rhEGF prevented the downregulation and disorder of nephrin but EGF-NtAb did not. Nuclei
were stained with DAPI (blue). Magnification = 600×, 1800 ×. DAPI, 4',6-diamidino-2-phenylindole; PI, propidium iodide.
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a relationship between the occurrence and development
of DN proteinuria and podocytic apoptosis and injury
[26,27]. Nephrin is a single-spanning transmembrane
immunoglobulin (Ig) superfamily protein and an integralcomponent of the podocyte slit diaphragm, a structure
important to the glomerular selectivity filter [28]. Glu-
cose at high levels could reduce the number and density
of podocytes, destroy the integrity of the glomerular fil-
tration membrane and change its selective permeability,
Li et al. Stem Cell Research & Therapy 2013, 4:103 Page 9 of 11
http://stemcellres.com/content/4/5/103so as to promote the progression of glomerular sclerosis
and accelerate the progress of DN [25,27]. Meanwhile,
the loss and injury of interacting proteins of podocytes,
such as synaptopodin and nephrin, could activate apop-
tosis and destroy the integrity of the slit membrane, so
as to aggravate proteinuria and accelerate the pro-
gression of DN [29]. Consequently, the apoptosis of
podocytes and injury of the synaptopodin, nephrin struc-
ture play important roles in the occurrence and deve-
lopment of DN. We established an in vitro model of
podocytic apoptosis and injury induced by HG. We
found that HG induced podocytic apoptosis, decreased
the expression of synaptopodin, nephrin and rearranged
the structure pattern of synaptopodin. These results are
consistent with previous reports [7,30].
Recent reports have demonstrated the capacity of
MSCs to repair tissue injuries [31]. MSCs transplant-
ation is considered safe and has been widely tested in
clinical trials with encouraging results [32]. Our finding
[33] and those of other researchers suggest that the ef-
fect of MSCs is mediated mainly by cytoprotective, anti-
apoptotic, anti-inflammatory factors [34,35], as well as
cellular differentiation [36]. In contrast to bone marrow
derived-MSCs, Ad-MSCs are more abundant and seem
to have several advantages in their differentiation cap-
acity and reparative function [37]. Our previous research
found that hAd-MSCs injected via the tail vein reduced
kidney injury in a cell localization-independent manner
in a type 1 DN rat model. Therefore, we hypothesized
that hAd-MSCs may prevent kidney injury through the
paracrine action of secreted cytokines. Adding MSCs-
CM to the medium of apoptotic podocytes induced by
HG, we found the process of apoptosis was inhibited by
MSCs-CM, and the decrease and the disorder of po-
docytic synaptopodin and nephrin were ameliorated by
MSCs-CM. It was reported that MSCs can secrete a
variety of soluble cytokines to induce the inhibition of
apoptosis and repair cell injury, including EGF, GDNF,
vascular endothelial growth factor (VEGF), PDGF,
IGFBP and IL-x, among others [17,38-40], and these
secreted factors can accumulate in CM. It has been
reported that MSC-CM has beneficial effects in a variety
of tissue repair and cell therapy models, including
inhibiting apoptosis and promoting healing and migra-
tion [41]. However, we found that WI38 fibroblasts-CM
failed to inhibit podocytic apoptosis or injury efficiently.
hAd-MSCs are fibroblast-like cells, but Wi38 fibroblasts
have no distinct characteristic of stem cells. We specu-
lated that the efficacy of MSCs was mainly due to their
‘stem cell characteristics’, that is, due to the differences
between MSCs-CM and WI38-CM.
We then analyzed the differences between MSCs-CM
and WI38-CM using an antibody-based cytokine array.
The results showed that the levels of IGFBP, GDNF,PIGF and EGF in MSCs-CM were significantly higher
than those in WI38-CM but only a dose of EGF equiva-
lent to that in CM could inhibit podocytic apoptosis effi-
ciently. Therefore, we chose EGF as the candidate. EGF
can promote the repair and regeneration of damaged
epidermis, and in both in vitro and in vivo experiments
EGF can induce anti-apoptosis and repair the damage of
epithelial cells, which was also seen in renal tubular epi-
thelial cells, intestinal epithelial cells, and vascular smooth
muscle cells [39,40,42]. Whether EGF can inhibit podo-
cytic apoptosis and injury induced by HG has not been
reported.
We found that EGF alone could inhibit podocytic
apoptosis injury induced by HG but these effects were
diminished by blocking EGF with NtAb. We suggest that
EGF is necessary for hAD-MSCs to exert their anti-
apoptosis and anti-injury therapeutic benefits to podo-
cytic apoptosis and injury induced by HG. One study
found that inhibition of EGFR induced the apoptosis
of intestinal epithelial cells through an EGF receptor
(EGFR)/p38α/mitogen-activated protein kinase (MAPK)/
Bax signaling pathway [42]. In addition, Caraglia et al.
reported that EGF inhibited IFN-α-induced apoptosis in
epidermoid tumors by activating the EGF-dependent
Ras/extracellular signal-regulated kinase (Erk) signaling
pathway [43]. However, Bollee et al. reported that epi-
dermal growth factor receptor (EGFR) promotes glom-
erular injury and renal failure in rapidly progressive
crescentic glomerulonephritis [44]. Maybe different me-
chanisms are involved in these studies. Targeting EGF
may have benefit in the diseased kidney. Nevertheless,
the mechanism through which EGF secreted into the
hAd-MSC-CM to prevent podocytic apoptosis and in-
jury induced by HG needs further study.Conclusions
Our findings suggest that hAd-MSCs reduce podocytic
apoptosis and injury induced by HG, likely by secreting
the cytoprotective factor EGF. To our limited know-
ledge, there has been no report relevant to the effects of
MSCs on podocytic injury induced by HG. Our findings
may help to develop a new therapeutic method to ameli-
orate the progress of DN and shed a new light on the
mechanisms of the beneficial effects of MSCs on DN.
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